Bank of Montreal’s PetMed Express PETS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,924
| Closed | -$84.4K | – | 3852 |
|
|
2024
Q3 | $84.4K | Buy |
22,924
+10,028
| +78% | +$35.5K | ﹤0.01% | 3293 |
|
|
2024
Q2 | $54K | Buy |
+12,896
| New | +$55.1K | ﹤0.01% | 3409 |
|
|
2023
Q3 | – | Sell |
-122,693
| Closed | -$1.85M | – | 4119 |
|
|
2023
Q2 | $1.85M | Buy |
+122,693
| New | +$1.84M | ﹤0.01% | 1858 |
|
|
2022
Q2 | – | Sell |
-8,839
| Closed | -$236K | – | 4346 |
|
|
2022
Q1 | $236K | Buy |
+8,839
| New | +$229K | ﹤0.01% | 3356 |
|
|
2021
Q4 | – | Sell |
-8,220
| Closed | -$231K | – | 3768 |
|
|
2021
Q3 | $231K | Buy |
8,220
+1,144
| +16% | +$33K | ﹤0.01% | 3267 |
|
|
2021
Q2 | $245K | Buy |
7,076
+1,361
| +24% | +$43.2K | ﹤0.01% | 3139 |
|
|
2021
Q1 | $189K | Buy |
5,715
+253
| +5% | +$8.8K | ﹤0.01% | 3141 |
|
|
2020
Q4 | $185K | Buy |
5,462
+3,683
| +207% | +$114K | ﹤0.01% | 3264 |
|
|
2020
Q3 | $55K | Sell |
1,779
-7,830
| -81% | -$259K | ﹤0.01% | 3389 |
|
|
2020
Q2 | $375K | Buy |
9,609
+8,904
| +1,263% | +$309K | ﹤0.01% | 2413 |
|
|
2020
Q1 | $21K | Sell |
705
-7,142
| -91% | -$187K | ﹤0.01% | 3230 |
|
|
2019
Q4 | $185K | Sell |
7,847
-17,587
| -69% | -$394K | ﹤0.01% | 3201 |
|
|
2019
Q3 | $459K | Buy |
25,434
+16,443
| +183% | +$272K | ﹤0.01% | 2461 |
|
|
2019
Q2 | $141K | Sell |
8,991
-33,442
| -79% | -$658K | ﹤0.01% | 3123 |
|
|
2019
Q1 | $966K | Buy |
42,433
+33,586
| +380% | +$757K | ﹤0.01% | 2036 |
|
|
2018
Q4 | $206K | Sell |
8,847
-7,438
| -46% | -$199K | ﹤0.01% | 2559 |
|
|
2018
Q3 | $537K | Sell |
16,285
-404
| -2% | -$15.1K | ﹤0.01% | 2302 |
|
|
2018
Q2 | $735K | Buy |
16,689
+5,292
| +46% | +$205K | ﹤0.01% | 2153 |
|
|
2018
Q1 | $476K | Buy |
11,397
+3,250
| +40% | +$150K | ﹤0.01% | 2243 |
|
|
2017
Q4 | $371K | Sell |
8,147
-149,593
| -95% | -$5.89M | ﹤0.01% | 2419 |
|
|
2017
Q3 | $5.23M | Buy |
157,740
+132,093
| +515% | +$5.38M | ﹤0.01% | 1152 |
|
|
2017
Q2 | $1.04M | Buy |
25,647
+18,000
| +235% | +$558K | ﹤0.01% | 1963 |
|
|
2017
Q1 | $154K | Hold |
7,647
| – | – | ﹤0.01% | 2609 |
|
|
2016
Q4 | $167K | Hold |
7,647
| – | – | ﹤0.01% | 2576 |
|
|
2016
Q3 | $155K | Hold |
7,647
| – | – | ﹤0.01% | 2555 |
|
|
2016
Q2 | $143K | Buy |
7,647
+328
| +4% | +$6.03K | ﹤0.01% | 2641 |
|
|
2016
Q1 | $131K | Buy |
7,319
+319
| +5% | +$5.46K | ﹤0.01% | 2681 |
|
|
2015
Q4 | $120K | Sell |
7,000
-8,000
| -53% | -$134K | ﹤0.01% | 2689 |
|
|
2015
Q3 | $242K | Hold |
15,000
| – | – | ﹤0.01% | 2169 |
|
|
2015
Q2 | $259K | Buy |
+15,000
| New | +$252K | ﹤0.01% | 2289 |
|
|
2015
Q1 | – | Sell |
-875
| Closed | -$13K | – | 4146 |
|
|
2014
Q4 | $13K | Hold |
875
| – | – | ﹤0.01% | 3486 |
|
|
2014
Q3 | $12K | Buy |
875
+375
| +75% | +$5.22K | ﹤0.01% | 3613 |
|
|
2014
Q2 | $7K | Sell |
500
-231
| -32% | -$3.05K | ﹤0.01% | 4018 |
|
|
2014
Q1 | $10K | Sell |
731
-660
| -47% | -$9.14K | ﹤0.01% | 3678 |
|
|
2013
Q4 | $23K | Sell |
1,391
-8,500
| -86% | -$133K | ﹤0.01% | 3186 |
|
|
2013
Q3 | $161K | Hold |
9,891
| – | – | ﹤0.01% | 2331 |
|
|
2013
Q2 | $124K | Buy |
+9,891
| New | +$129K | ﹤0.01% | 2355 |
|
Other funds holding PETS
OCMI
MC
Bank of Montreal's PETS Position: Q4 2024 in Review
Bank of Montreal sold out of PetMed Express (PETS) in Q4 2024, closing a stake of 22,924 shares — an estimated $84.4K sold.
Bank of Montreal first reported a position in PETS in Q2 2013 and held it in 37 quarters. The position peaked at $5.23M in Q3 2017. 86 funds tracked by Wall St. Rank hold PETS as of Q4 2024.
- Bank of Montreal reported no remaining PetMed Express position as of Q4 2024 after selling out during the quarter.
- Bank of Montreal sold 22,924 PetMed Express shares in Q4 2024, an estimated $84.4K.
- Bank of Montreal first reported a position in PetMed Express in Q2 2013 and held it in 37 quarters.
- Bank of Montreal's PetMed Express position peaked at $5.23M in Q3 2017.
- 86 funds tracked by Wall St. Rank held PetMed Express as of Q4 2024.
Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.